It is still at the mice testing stage, but 80% tested had a reversal of diabetes and in other cases it prevented the onset of diabetes. Side effects, etc. will need to be studied as well, but this looks very promising if in fact the drugs can prevent diabetes for many, especially children if their...
Posted to
The Medical Quack .... by Barbara Duck
on 11-19-2008
Filed under: Medically Related, Pharma/FDA News, personalized medicine, healthcare, Cancer, Diabetes, R and D, San Francisco University of California
The National Cancer Institute has made clinical trial participation a top national priority and yet participant levels are still not perhaps where they could be. Yes, this is a big decision for any patient/physician to make as far as whether or not to enroll, but many trials are offering lifesaving...
Posted to
The Medical Quack .... by Barbara Duck
on 11-02-2008
Filed under: Medically Related, Pharma/FDA News, My Commentaries, Investors, health insurance, Pharma, Cancer, clinical trials, HMO, Pharmaceuticals, R and D, Drug Development, Cancer Institute
10 genetic mutations were found in the patient's tumor and virtually every cell in the tumor sample had nine of the mutations. “What's striking about the new research is that the scientists were able to sift through the 3 billion pairs of chemical bases that make up the human genome to...
Posted to
The Medical Quack .... by Barbara Duck
on 10-31-2008
Filed under: Medically Related, Technology, Pharma/FDA News, Other Items of Interest, Genomics, Cancer, R and D, DNA Testing, Sequencing
Even folks with money and in high positions have problems getting access to cancer drugs, as you can read below, and this was not an issue of not being able to afford the medication. When you read items as such, it makes you stop and think how precious life and healthcare really is. BD ...
Posted to
The Medical Quack .... by Barbara Duck
on 10-31-2008
Filed under: Medically Related, Pharma/FDA News, Other Items of Interest, drugs, Cancer, Tysabri, Access to medications, Cancer Drugs, Fred Baron, Biogen
According to the study, statins are lowering the PSA levels, but the concern is whether or not this could be hiding or clouding the issues and cancer could be potentially missed in the diagnosis as they are not sure if this is lowering the test numbers or if it is in fact helping in the prevention of...
It is here but evolving slower than what all of us might like to see, and in many areas it is still so much of a “Science” but as developments occur through biotech we are seeing some amazing results. There’s also the bridging of the gap with bringing genomics to the point of care, as physicians...
Posted to
The Medical Quack .... by Barbara Duck
on 10-26-2008
Filed under: Medically Related, Technology, Pharma/FDA News, personalized medicine, healthcare, Pharma, Biotech, Cancer, tumors, Genentech, Herceptin, cancer vaccine
One thing that comes to mind is what a waste of talent here. Series of events lead up to where he is today, but started when he ran out of money for his research related to the GFP gene and cancer. “Researchers worldwide now use GFP to track development of brain cells, the growth of tumors...
Posted to
The Medical Quack .... by Barbara Duck
on 10-14-2008
Filed under: Medically Related, Technology, Pharma/FDA News, personalized medicine, Genomics, healthcare, Cancer, R and D, GFP Gene, Nobel Prize